A Clinical Decision Support Tool To Predict Survival in Cancer Patients beyond 120 Days after Palliative Chemotherapy
Author:
Affiliation:
1. Department of Pharmacy, National University of Singapore, Singapore.
2. Department of Pharmacy, National Cancer Centre Singapore, Singapore.
Publisher
Mary Ann Liebert Inc
Subject
Anesthesiology and Pain Medicine,General Medicine,General Nursing
Link
http://www.liebertpub.com/doi/pdf/10.1089/jpm.2011.0417
Reference27 articles.
1. Palliative chemotherapy: Historical perspective, applications, and controversies
2. Treatment options in end-of-life care: the role of palliative chemotherapy
3. A systematic review of physicians' survival predictions in terminally ill cancer patients
4. Survival Prediction in Terminally Ill Cancer Patients by Clinical Estimates, Laboratory Tests, and Self-Rated Anxiety and Depression
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Artificial Intelligence–Based Consumer Health Informatics Application: Scoping Review (Preprint);2023-03-13
2. Digital technologies and the democratization of clinical research: Social media, wearables, and artificial intelligence;Contemporary Clinical Trials;2022-06
3. Key use cases for artificial intelligence to reduce the frequency of adverse drug events: a scoping review;The Lancet Digital Health;2022-02
4. The Next Generation of eHealth: A Multidisciplinary Survey;IEEE Access;2022
5. Integration of AI for Clinical Decision Support;Cognitive Informatics in Biomedicine and Healthcare;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3